The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Pain Medicines Market Research Report 2025
Synopsis
The global OTC Pain Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Pain Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Pain Medicines.
Report Scope
The OTC Pain Medicines market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Pain Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Pain Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Novartis
Sanofi
Bayer
Mallinckrodt
Anqiu Lu'an
Granules India
Farmson
Hebei Jiheng
Zhejiang Kangle
Sri Krishna Pharma
Anhui BBCA Likang
Seqens
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Segment by Type
Acetaminophen
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Pain Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Pain Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global OTC Pain Medicines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Pain Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Pain Medicines.
Report Scope
The OTC Pain Medicines market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Pain Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Pain Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Pfizer
Novartis
Sanofi
Bayer
Mallinckrodt
Anqiu Lu'an
Granules India
Farmson
Hebei Jiheng
Zhejiang Kangle
Sri Krishna Pharma
Anhui BBCA Likang
Seqens
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Segment by Type
Acetaminophen
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Pain Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Pain Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Pain Medicines Market Overview
1.1 Product Overview and Scope of OTC Pain Medicines
1.2 OTC Pain Medicines Segment by Type
1.2.1 Global OTC Pain Medicines Market Value Comparison by Type (2024-2030)
1.2.2 Acetaminophen
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 OTC Pain Medicines Segment by Application
1.3.1 Global OTC Pain Medicines Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Global OTC Pain Medicines Market Size Estimates and Forecasts
1.4.1 Global OTC Pain Medicines Revenue 2019-2030
1.4.2 Global OTC Pain Medicines Sales 2019-2030
1.4.3 Global OTC Pain Medicines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Pain Medicines Market Competition by Manufacturers
2.1 Global OTC Pain Medicines Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Pain Medicines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Pain Medicines Average Price by Manufacturers (2019-2024)
2.4 Global OTC Pain Medicines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Pain Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Pain Medicines, Product Type & Application
2.7 OTC Pain Medicines Market Competitive Situation and Trends
2.7.1 OTC Pain Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Pain Medicines Players Market Share by Revenue
2.7.3 Global OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Pain Medicines Retrospective Market Scenario by Region
3.1 Global OTC Pain Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Pain Medicines Global OTC Pain Medicines Sales by Region: 2019-2030
3.2.1 Global OTC Pain Medicines Sales by Region: 2019-2024
3.2.2 Global OTC Pain Medicines Sales by Region: 2025-2030
3.3 Global OTC Pain Medicines Global OTC Pain Medicines Revenue by Region: 2019-2030
3.3.1 Global OTC Pain Medicines Revenue by Region: 2019-2024
3.3.2 Global OTC Pain Medicines Revenue by Region: 2025-2030
3.4 North America OTC Pain Medicines Market Facts & Figures by Country
3.4.1 North America OTC Pain Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Pain Medicines Sales by Country (2019-2030)
3.4.3 North America OTC Pain Medicines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Pain Medicines Market Facts & Figures by Country
3.5.1 Europe OTC Pain Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Pain Medicines Sales by Country (2019-2030)
3.5.3 Europe OTC Pain Medicines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Pain Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Pain Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Pain Medicines Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Pain Medicines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Pain Medicines Market Facts & Figures by Country
3.7.1 Latin America OTC Pain Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Pain Medicines Sales by Country (2019-2030)
3.7.3 Latin America OTC Pain Medicines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Pain Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Pain Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Pain Medicines Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Pain Medicines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Pain Medicines Sales by Type (2019-2030)
4.1.1 Global OTC Pain Medicines Sales by Type (2019-2024)
4.1.2 Global OTC Pain Medicines Sales by Type (2025-2030)
4.1.3 Global OTC Pain Medicines Sales Market Share by Type (2019-2030)
4.2 Global OTC Pain Medicines Revenue by Type (2019-2030)
4.2.1 Global OTC Pain Medicines Revenue by Type (2019-2024)
4.2.2 Global OTC Pain Medicines Revenue by Type (2025-2030)
4.2.3 Global OTC Pain Medicines Revenue Market Share by Type (2019-2030)
4.3 Global OTC Pain Medicines Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Pain Medicines Sales by Application (2019-2030)
5.1.1 Global OTC Pain Medicines Sales by Application (2019-2024)
5.1.2 Global OTC Pain Medicines Sales by Application (2025-2030)
5.1.3 Global OTC Pain Medicines Sales Market Share by Application (2019-2030)
5.2 Global OTC Pain Medicines Revenue by Application (2019-2030)
5.2.1 Global OTC Pain Medicines Revenue by Application (2019-2024)
5.2.2 Global OTC Pain Medicines Revenue by Application (2025-2030)
5.2.3 Global OTC Pain Medicines Revenue Market Share by Application (2019-2030)
5.3 Global OTC Pain Medicines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline OTC Pain Medicines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer OTC Pain Medicines Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis OTC Pain Medicines Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi OTC Pain Medicines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer OTC Pain Medicines Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Mallinckrodt
6.6.1 Mallinckrodt Corporation Information
6.6.2 Mallinckrodt Description and Business Overview
6.6.3 Mallinckrodt OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mallinckrodt OTC Pain Medicines Product Portfolio
6.6.5 Mallinckrodt Recent Developments/Updates
6.7 Anqiu Lu'an
6.6.1 Anqiu Lu'an Corporation Information
6.6.2 Anqiu Lu'an Description and Business Overview
6.6.3 Anqiu Lu'an OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anqiu Lu'an OTC Pain Medicines Product Portfolio
6.7.5 Anqiu Lu'an Recent Developments/Updates
6.8 Granules India
6.8.1 Granules India Corporation Information
6.8.2 Granules India Description and Business Overview
6.8.3 Granules India OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Granules India OTC Pain Medicines Product Portfolio
6.8.5 Granules India Recent Developments/Updates
6.9 Farmson
6.9.1 Farmson Corporation Information
6.9.2 Farmson Description and Business Overview
6.9.3 Farmson OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Farmson OTC Pain Medicines Product Portfolio
6.9.5 Farmson Recent Developments/Updates
6.10 Hebei Jiheng
6.10.1 Hebei Jiheng Corporation Information
6.10.2 Hebei Jiheng Description and Business Overview
6.10.3 Hebei Jiheng OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hebei Jiheng OTC Pain Medicines Product Portfolio
6.10.5 Hebei Jiheng Recent Developments/Updates
6.11 Zhejiang Kangle
6.11.1 Zhejiang Kangle Corporation Information
6.11.2 Zhejiang Kangle OTC Pain Medicines Description and Business Overview
6.11.3 Zhejiang Kangle OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zhejiang Kangle OTC Pain Medicines Product Portfolio
6.11.5 Zhejiang Kangle Recent Developments/Updates
6.12 Sri Krishna Pharma
6.12.1 Sri Krishna Pharma Corporation Information
6.12.2 Sri Krishna Pharma OTC Pain Medicines Description and Business Overview
6.12.3 Sri Krishna Pharma OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sri Krishna Pharma OTC Pain Medicines Product Portfolio
6.12.5 Sri Krishna Pharma Recent Developments/Updates
6.13 Anhui BBCA Likang
6.13.1 Anhui BBCA Likang Corporation Information
6.13.2 Anhui BBCA Likang OTC Pain Medicines Description and Business Overview
6.13.3 Anhui BBCA Likang OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Anhui BBCA Likang OTC Pain Medicines Product Portfolio
6.13.5 Anhui BBCA Likang Recent Developments/Updates
6.14 Seqens
6.14.1 Seqens Corporation Information
6.14.2 Seqens OTC Pain Medicines Description and Business Overview
6.14.3 Seqens OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Seqens OTC Pain Medicines Product Portfolio
6.14.5 Seqens Recent Developments/Updates
6.15 Xinhua Pharmaceutical
6.15.1 Xinhua Pharmaceutical Corporation Information
6.15.2 Xinhua Pharmaceutical OTC Pain Medicines Description and Business Overview
6.15.3 Xinhua Pharmaceutical OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Xinhua Pharmaceutical OTC Pain Medicines Product Portfolio
6.15.5 Xinhua Pharmaceutical Recent Developments/Updates
6.16 IOLCP
6.16.1 IOLCP Corporation Information
6.16.2 IOLCP OTC Pain Medicines Description and Business Overview
6.16.3 IOLCP OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 IOLCP OTC Pain Medicines Product Portfolio
6.16.5 IOLCP Recent Developments/Updates
6.17 Granules Biocause
6.17.1 Granules Biocause Corporation Information
6.17.2 Granules Biocause OTC Pain Medicines Description and Business Overview
6.17.3 Granules Biocause OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Granules Biocause OTC Pain Medicines Product Portfolio
6.17.5 Granules Biocause Recent Developments/Updates
6.18 Strides Shasun
6.18.1 Strides Shasun Corporation Information
6.18.2 Strides Shasun OTC Pain Medicines Description and Business Overview
6.18.3 Strides Shasun OTC Pain Medicines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Strides Shasun OTC Pain Medicines Product Portfolio
6.18.5 Strides Shasun Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Pain Medicines Industry Chain Analysis
7.2 OTC Pain Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Pain Medicines Production Mode & Process
7.4 OTC Pain Medicines Sales and Marketing
7.4.1 OTC Pain Medicines Sales Channels
7.4.2 OTC Pain Medicines Distributors
7.5 OTC Pain Medicines Customers
8 OTC Pain Medicines Market Dynamics
8.1 OTC Pain Medicines Industry Trends
8.2 OTC Pain Medicines Market Drivers
8.3 OTC Pain Medicines Market Challenges
8.4 OTC Pain Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Pain Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Pain Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OTC Pain Medicines Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Pain Medicines Sales (Kiloton) of Key Manufacturers (2019-2024)
Table 5. Global OTC Pain Medicines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Pain Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Pain Medicines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Pain Medicines Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Pain Medicines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Pain Medicines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Pain Medicines, Product Type & Application
Table 12. Global Key Manufacturers of OTC Pain Medicines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Pain Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Pain Medicines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Pain Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Pain Medicines Sales by Region (2019-2024) & (Kiloton)
Table 18. Global OTC Pain Medicines Sales Market Share by Region (2019-2024)
Table 19. Global OTC Pain Medicines Sales by Region (2025-2030) & (Kiloton)
Table 20. Global OTC Pain Medicines Sales Market Share by Region (2025-2030)
Table 21. Global OTC Pain Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Pain Medicines Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Pain Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Pain Medicines Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Pain Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Pain Medicines Sales by Country (2019-2024) & (Kiloton)
Table 27. North America OTC Pain Medicines Sales by Country (2025-2030) & (Kiloton)
Table 28. North America OTC Pain Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Pain Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Pain Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Pain Medicines Sales by Country (2019-2024) & (Kiloton)
Table 32. Europe OTC Pain Medicines Sales by Country (2025-2030) & (Kiloton)
Table 33. Europe OTC Pain Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Pain Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Pain Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Pain Medicines Sales by Region (2019-2024) & (Kiloton)
Table 37. Asia Pacific OTC Pain Medicines Sales by Region (2025-2030) & (Kiloton)
Table 38. Asia Pacific OTC Pain Medicines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Pain Medicines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Pain Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Pain Medicines Sales by Country (2019-2024) & (Kiloton)
Table 42. Latin America OTC Pain Medicines Sales by Country (2025-2030) & (Kiloton)
Table 43. Latin America OTC Pain Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Pain Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Pain Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Pain Medicines Sales by Country (2019-2024) & (Kiloton)
Table 47. Middle East & Africa OTC Pain Medicines Sales by Country (2025-2030) & (Kiloton)
Table 48. Middle East & Africa OTC Pain Medicines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Pain Medicines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Pain Medicines Sales (Kiloton) by Type (2019-2024)
Table 51. Global OTC Pain Medicines Sales (Kiloton) by Type (2025-2030)
Table 52. Global OTC Pain Medicines Sales Market Share by Type (2019-2024)
Table 53. Global OTC Pain Medicines Sales Market Share by Type (2025-2030)
Table 54. Global OTC Pain Medicines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Pain Medicines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Pain Medicines Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Pain Medicines Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Pain Medicines Price (US$/Ton) by Type (2019-2024)
Table 59. Global OTC Pain Medicines Price (US$/Ton) by Type (2025-2030)
Table 60. Global OTC Pain Medicines Sales (Kiloton) by Application (2019-2024)
Table 61. Global OTC Pain Medicines Sales (Kiloton) by Application (2025-2030)
Table 62. Global OTC Pain Medicines Sales Market Share by Application (2019-2024)
Table 63. Global OTC Pain Medicines Sales Market Share by Application (2025-2030)
Table 64. Global OTC Pain Medicines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OTC Pain Medicines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OTC Pain Medicines Revenue Market Share by Application (2019-2024)
Table 67. Global OTC Pain Medicines Revenue Market Share by Application (2025-2030)
Table 68. Global OTC Pain Medicines Price (US$/Ton) by Application (2019-2024)
Table 69. Global OTC Pain Medicines Price (US$/Ton) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline OTC Pain Medicines Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Pfizer OTC Pain Medicines Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Novartis OTC Pain Medicines Product
Table 84. Novartis Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Sanofi OTC Pain Medicines Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Bayer OTC Pain Medicines Product
Table 94. Bayer Recent Developments/Updates
Table 95. Mallinckrodt Corporation Information
Table 96. Mallinckrodt Description and Business Overview
Table 97. Mallinckrodt OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Mallinckrodt OTC Pain Medicines Product
Table 99. Mallinckrodt Recent Developments/Updates
Table 100. Anqiu Lu'an Corporation Information
Table 101. Anqiu Lu'an Description and Business Overview
Table 102. Anqiu Lu'an OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Anqiu Lu'an OTC Pain Medicines Product
Table 104. Anqiu Lu'an Recent Developments/Updates
Table 105. Granules India Corporation Information
Table 106. Granules India Description and Business Overview
Table 107. Granules India OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Granules India OTC Pain Medicines Product
Table 109. Granules India Recent Developments/Updates
Table 110. Farmson Corporation Information
Table 111. Farmson Description and Business Overview
Table 112. Farmson OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Farmson OTC Pain Medicines Product
Table 114. Farmson Recent Developments/Updates
Table 115. Hebei Jiheng Corporation Information
Table 116. Hebei Jiheng Description and Business Overview
Table 117. Hebei Jiheng OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Hebei Jiheng OTC Pain Medicines Product
Table 119. Hebei Jiheng Recent Developments/Updates
Table 120. Zhejiang Kangle Corporation Information
Table 121. Zhejiang Kangle Description and Business Overview
Table 122. Zhejiang Kangle OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Zhejiang Kangle OTC Pain Medicines Product
Table 124. Zhejiang Kangle Recent Developments/Updates
Table 125. Sri Krishna Pharma Corporation Information
Table 126. Sri Krishna Pharma Description and Business Overview
Table 127. Sri Krishna Pharma OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Sri Krishna Pharma OTC Pain Medicines Product
Table 129. Sri Krishna Pharma Recent Developments/Updates
Table 130. Anhui BBCA Likang Corporation Information
Table 131. Anhui BBCA Likang Description and Business Overview
Table 132. Anhui BBCA Likang OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Anhui BBCA Likang OTC Pain Medicines Product
Table 134. Anhui BBCA Likang Recent Developments/Updates
Table 135. Seqens Corporation Information
Table 136. Seqens Description and Business Overview
Table 137. Seqens OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 138. Seqens OTC Pain Medicines Product
Table 139. Seqens Recent Developments/Updates
Table 140. Xinhua Pharmaceutical Corporation Information
Table 141. Xinhua Pharmaceutical Description and Business Overview
Table 142. Xinhua Pharmaceutical OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 143. Xinhua Pharmaceutical OTC Pain Medicines Product
Table 144. Xinhua Pharmaceutical Recent Developments/Updates
Table 145. IOLCP Corporation Information
Table 146. IOLCP Description and Business Overview
Table 147. IOLCP OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 148. IOLCP OTC Pain Medicines Product
Table 149. IOLCP Recent Developments/Updates
Table 150. Granules Biocause Corporation Information
Table 151. Granules Biocause Description and Business Overview
Table 152. Granules Biocause OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 153. Granules Biocause OTC Pain Medicines Product
Table 154. Granules Biocause Recent Developments/Updates
Table 155. Strides Shasun Corporation Information
Table 156. Strides Shasun Description and Business Overview
Table 157. Strides Shasun OTC Pain Medicines Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 158. Strides Shasun OTC Pain Medicines Product
Table 159. Strides Shasun Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. OTC Pain Medicines Distributors List
Table 163. OTC Pain Medicines Customers List
Table 164. OTC Pain Medicines Market Trends
Table 165. OTC Pain Medicines Market Drivers
Table 166. OTC Pain Medicines Market Challenges
Table 167. OTC Pain Medicines Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Pain Medicines
Figure 2. Global OTC Pain Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Pain Medicines Market Share by Type in 2023 & 2030
Figure 4. Acetaminophen Product Picture
Figure 5. Ibuprofen Product Picture
Figure 6. Aspirin Product Picture
Figure 7. Naproxen Product Picture
Figure 8. Others Product Picture
Figure 9. Global OTC Pain Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global OTC Pain Medicines Market Share by Application in 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Drug Stores
Figure 13. E-Commerce
Figure 14. Global OTC Pain Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global OTC Pain Medicines Market Size (2019-2030) & (US$ Million)
Figure 16. Global OTC Pain Medicines Sales (2019-2030) & (Kiloton)
Figure 17. Global OTC Pain Medicines Average Price (US$/Ton) & (2019-2030)
Figure 18. OTC Pain Medicines Report Years Considered
Figure 19. OTC Pain Medicines Sales Share by Manufacturers in 2023
Figure 20. Global OTC Pain Medicines Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest OTC Pain Medicines Players: Market Share by Revenue in 2023
Figure 22. OTC Pain Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global OTC Pain Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America OTC Pain Medicines Sales Market Share by Country (2019-2030)
Figure 25. North America OTC Pain Medicines Revenue Market Share by Country (2019-2030)
Figure 26. United States OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe OTC Pain Medicines Sales Market Share by Country (2019-2030)
Figure 29. Europe OTC Pain Medicines Revenue Market Share by Country (2019-2030)
Figure 30. Germany OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific OTC Pain Medicines Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific OTC Pain Medicines Revenue Market Share by Region (2019-2030)
Figure 37. China OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America OTC Pain Medicines Sales Market Share by Country (2019-2030)
Figure 47. Latin America OTC Pain Medicines Revenue Market Share by Country (2019-2030)
Figure 48. Mexico OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa OTC Pain Medicines Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa OTC Pain Medicines Revenue Market Share by Country (2019-2030)
Figure 53. Turkey OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE OTC Pain Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of OTC Pain Medicines by Type (2019-2030)
Figure 57. Global Revenue Market Share of OTC Pain Medicines by Type (2019-2030)
Figure 58. Global OTC Pain Medicines Price (US$/Ton) by Type (2019-2030)
Figure 59. Global Sales Market Share of OTC Pain Medicines by Application (2019-2030)
Figure 60. Global Revenue Market Share of OTC Pain Medicines by Application (2019-2030)
Figure 61. Global OTC Pain Medicines Price (US$/Ton) by Application (2019-2030)
Figure 62. OTC Pain Medicines Value Chain
Figure 63. OTC Pain Medicines Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
